<DOC>
	<DOCNO>NCT02010632</DOCNO>
	<brief_summary>The purpose study compare pharmacodynamic effect clopidogrel platelet inhibition pharmacokinetic profile clopidogrel carboxylic acid metabolite generic reference clopidogrel product Thai healthy volunteer</brief_summary>
	<brief_title>Comparative Pharmacodynamics Pharmacokinetics Study Generic Reference Clopidogrel Products</brief_title>
	<detailed_description>Platelet aggregation ( ex vivo ) measure use Whole blood impedence aggregometry ( Chrono-log® ) VerifyNow® P2Y12 assay . Plasma concentration clopidogrel carboxylic acid metabolite measure High performance liquid chromatography ( HPLC ) .</detailed_description>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<criteria>Age 18 45 year Body mass index 1825 kg/m2 No clinically significant abnormality , confirm medical history ; detailed physical examination ; clinical laboratory analysis ( blood hematology , biochemistry , prothrombin time , bleed time , urinalysis ) An allergy drug ; and/or history drug and/or alcohol abuse . Subjects donate blood within 3 month prior start study participate another investigational drug study within 3 month prior start study Participating subject instruct abstain use drug least 2 week throughout study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Clopidogrel</keyword>
	<keyword>Platelet inhibition</keyword>
	<keyword>Platelet aggregation</keyword>
</DOC>